An association between dyslipidemia, the oxidation of LDL, CD36, ROS generation, TXNIP upregulation, NLRP3 inflammasome activation, and dysbiosis has been demonstrated in the present study through the action of DSS in HFD-fed rats. The gene discussed is NLRP3; the disease is metabolic syndrome.